A 1 ASP 16 -10.922 -11.506
A 2 GLN 8 -13.336 -12.722
A 3 VAL 31 -15.699 -17.459
A 4 ASP 7 -16.007 -14.971
A 5 VAL 31 -18.012 -19.506
A 6 LYS 10 -17.802 -16.905
A 7 ASP 15 -19.072 -18.604
A 8 CYS 16 -19.176 -18.811
A 9 ALA 26 -16.453 -17.551
A 10 ASN 16 -13.180 -13.505
A 11 HIS 0 -14.586 -12.909
A 12 GLU 27 -13.325 -14.897
A 13 ILE 27 -16.828 -17.998
A 14 LYS 13 -14.785 -14.580
A 15 LYS 13 -16.408 -16.016
A 16 VAL 28 -16.961 -18.231
A 17 LEU 11 -15.588 -15.061
A 18 VAL 28 -14.065 -15.667
A 19 PRO 13 -9.368 -9.786
A 20 GLY 13 -7.008 -7.697
A 21 CYS 27 -10.672 -12.549
A 22 HIS 1 -6.281 -5.674
A 23 GLY 0 -6.311 -5.585
A 24 SER 10 -5.785 -6.270
A 25 GLU 7 -8.205 -8.066
A 26 PRO 17 -9.163 -10.064
A 27 CYS 27 -11.764 -13.516
A 28 ILE 5 -8.957 -8.502
A 29 ILE 32 -10.344 -12.834
A 30 HIS 8 -5.374 -5.676
A 31 ARG 14 -5.252 -6.258
A 32 GLY 6 -2.795 -3.163 <=B
A 33 LYS 14 -3.518 -4.723
A 34 PRO 6 -5.959 -5.964
A 35 PHE 26 -8.754 -10.738
A 36 GLN 10 -11.126 -10.996
A 37 LEU 32 -15.953 -17.799
A 38 GLU 10 -15.317 -14.705
A 39 ALA 26 -17.112 -18.134
A 40 LEU 10 -16.001 -15.311
A 41 PHE 38 -16.010 -18.539
A 42 GLU 8 -11.498 -11.096
A 43 ALA 22 -11.254 -12.490
A 44 ASN 14 -9.002 -9.576
A 45 GLN 16 -7.031 -8.063
A 46 ASN 0 -5.471 -4.842
A 47 SER 25 -7.667 -9.660
A 48 ALA 2 -6.477 -5.962
A 49 LYS 9 -8.948 -8.954
A 50 ILE 30 -13.523 -15.418
A 51 GLU 11 -15.661 -15.125
A 52 ILE 23 -16.968 -17.661
A 53 LYS 15 -16.745 -16.544
A 54 ALA 28 -17.182 -18.427
A 55 SER 11 -16.021 -15.443
A 56 ILE 23 -14.496 -15.474
A 57 ASP 11 -12.664 -12.473
A 58 GLY 0 -11.944 -10.570
A 59 LEU 13 -11.085 -11.306
A 60 GLU 7 -11.885 -11.323
A 61 VAL 23 -13.545 -14.633
A 62 ASP 9 -12.768 -12.335
A 63 VAL 25 -14.513 -15.719
A 64 PRO 7 -11.210 -10.726
A 65 GLY 15 -10.562 -11.072
A 66 ILE 29 -12.436 -14.341
A 67 ASP 6 -8.972 -8.630
A 68 PRO 15 -9.143 -9.816
A 69 ASN 0 -5.566 -4.926
A 70 ALA 6 -5.811 -5.833
A 71 CYS 0 -4.569 -4.044
A 72 HIS 4 -4.409 -4.362
A 73 TYR 25 -7.340 -9.371
A 74 MET 2 -6.097 -5.626
A 75 LEU 32 -8.676 -11.358
A 76 VAL 3 -5.887 -5.555
A 77 LYS 8 -4.917 -5.271
A 78 GLY 0 -5.678 -5.025
A 79 GLN 12 -6.161 -6.832
A 80 GLN 9 -9.148 -9.131
A 81 TYR 26 -11.301 -12.991
A 82 ASP 5 -13.421 -12.453
A 83 ILE 33 -14.684 -16.791
A 84 LYS 2 -13.456 -12.138
A 85 TYR 24 -13.341 -14.567
A 86 THR 3 -11.157 -10.219
A 87 TRP 31 -12.652 -14.762
A 88 ASN 7 -7.428 -7.378
A 89 VAL 29 -8.774 -11.100
A 90 PRO 15 -5.831 -6.885
A 91 LYS 1 -1.783 -1.693 <=B
A 92 ILE 7 -2.083 -2.649 <=B
A 93 ALA 31 -7.579 -10.272
A 94 PRO 13 -6.682 -7.409
A 95 LYS 4 -5.864 -5.650
A 96 SER 20 -9.565 -10.765
A 97 GLU 7 -11.761 -11.214
A 98 ASN 7 -13.946 -13.147
A 99 VAL 32 -17.115 -18.827
A 100 VAL 12 -18.216 -17.501
A 101 VAL 37 -19.004 -21.074
A 102 THR 17 -19.495 -19.208
A 103 VAL 35 -18.731 -20.602
A 104 LYS 13 -16.426 -16.032
A 105 VAL 23 -13.177 -14.307
A 106 ASP 14 -7.974 -8.667
A 107 ASN 11 -7.317 -7.741
A 108 GLY 9 -11.343 -11.073
A 109 VAL 15 -15.481 -15.425
A 110 LEU 33 -16.268 -18.192
A 111 ALA 36 -20.151 -21.974
A 112 CYS 9 -20.404 -19.093
A 113 ALA 25 -19.928 -20.511
A 114 ILE 10 -19.086 -18.041
A 115 ALA 33 -18.466 -20.137
A 116 THR 11 -15.526 -15.006
A 117 HIS 16 -13.223 -13.543
A 118 ALA 32 -13.836 -15.925
A 119 LYS 10 -11.206 -11.067
A 120 ILE 28 -9.556 -11.677
A 121 ARG 8 -4.375 -4.792
A 122 ASP 0 -1.603 -1.419 <=B

Identified 4 B-Cell epitope residues out of 122 total residues